CrossrefInfokarte
Selective estrogen receptor degraders in premenopausal breast cancer: Biological activity and endpoint relevance in window of opportunity trials
Cancer Treatment Reviews · 2026-11 · 150 · 103213
DOI: 10.1016/j.ctrv.2026.103213 ↗Abstract
Kein Abstract verfügbar.
EUVIMED